The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index; none of the 4 sources its claims cite is checked for support yet.
Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression
Open accessAbstract
SUMMARY While many genetic variants have been associated with risk for human diseases, how these variants affect gene expression in various cell types remains largely unknown. To address this gap, the DICE (Database of Immune Cell Expression, Expression quantitative trait loci (eQTLs) and Epigenomics) project was established. Considering all human immune cell types and conditions studied, we identified cis-eQTLs for a total of 12,254 unique genes, which represent 61% of all protein-coding genes expressed in these cell types. Strikingly, a large fraction (41%) of these genes showed a strong cis-association with genotype only in a single cell type. We also found that biological sex is associated with major differences in immune cell gene expression in a highly cell-specific manner. These datasets will help reveal the effects of disease risk-associated genetic polymorphisms on specific immune cell types, providing mechanistic insights into how they might influence pathogenesis (http://dice-database.org).
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
The DICE project mapped transcriptomes and cis-eQTLs across 13 human immune cell types and activation conditions from 91 healthy subjects, identifying 12,254 eGenes with highly cell-specific genetic effects. It also found extensive sex-biased immune gene expression and linked GWAS disease variants to specific immune cell types.
Key findings
- cis-eQTLs were identified for 12,254 unique genes, representing 61% of expressed protein-coding genes and 49% of lncRNAs; 41% showed a strong cis-association with genotype in only a single cell type. More than 2,000 eGenes were found per common cell type, and CD4+ memory/TREG subsets yielded over 7,800 eGenes, of which >2,500 were unique to those subsets.
- About 19% of eGenes per immune cell type overlapped GWAS SNPs (2,297 unique GWAS eGenes; 599–987 eGenes/cell type), and for about 36% of these eGenes associations were observed in only one or two cell types. Examples included IRAK3 in naïve B cells (rs1732886, adj. P = 6.82 × 10−17) and NAB1 in NK cells (rs13028201, adj. P = 1.41 × 10−14).
- Sex-biased expression was found for 1,875 unique transcripts, including 1,553 protein-coding transcripts and 196 lncRNAs; 93% were autosomal and >72% showed sex-biased expression in only a single immune cell type. FAM13A was female-biased in naïve CD4+ T cells, with homozygous CC versus TT females showing 3.5-fold greater FAM13A transcripts compared to <1.5-fold in males.
- Cell-specific transcriptional signatures included 4,602 highly cell-specific transcripts, and differential expression among CD4+ T cell subsets revealed over 700 genes enriched in one specific subset.
Methods
- The study analyzed 13 immune cell types plus activated naïve CD4+ and CD8+ T cells from 106 leukapheresis samples provided by 91 healthy subjects (54 males, 37 females; median age 27 years, range 18–61).
- RNA-seq was performed on FACS-sorted cells, with genotyping and imputation using the 1,000 Genomes Project phase 3 reference; cis-eQTLs were tested within ±1 Mb of the transcription start site using Matrix eQTL with thresholds FDR < 0.05, raw P < 0.0001, and TPM > 1.0.
- Differential expression used DESeq2; GWAS overlap used PheGenI data with 14,321 lead GWAS SNPs and 846 traits; functional validation used siRNA knockdowns in primary immune cells.
Limitations
- The paper states that next phases of DICE will add additional rare immune cell types and cell-specific epigenomic profiles, and that several lncRNA and disease-gene links require further study and functional confirmation.
- The cohort was limited to 91 healthy volunteers from the San Diego area with a median age of 27 years, so generalizability to older, diseased, or more ancestrally diverse populations is not established by this dataset.
- The eQTL analysis did not cover the pseudoautosomal regions of chr X or chr Y (stated in the paper), and it focused on cis windows of ±1 Mb around the TSS rather than trans effects.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
68 Own result · 15 Own method · 8 Own interpretation · 4 Not checked yet
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“which as a class were expressed at lower levels compared to protein-coding transcripts”
§ Impact of genetic polymorphisms on human immune cell gene expression > RESULTS > Transcriptome of common human immune cell types
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Considering all human immune cell types and conditions studied, we identified cis-eQTLs for a total of 12,254 unique genes”
§ Impact of genetic polymorphisms on human immune cell gene expression > Abstract
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“RNA-Seq analysis showed that similar numbers of transcripts (ranging from 14,500 to 17,000, ~39% of all annotated transcripts) were detected (>1.0 transcripts per million, TPM) across all cell types and activation conditions”
§ Impact of genetic polymorphisms on human immune cell gene expression > RESULTS > Transcriptome of common human immune cell types
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We also found that biological sex is associated with major differences in immune cell gene expression in a highly cell-specific manner.”
§ Impact of genetic polymorphisms on human immune cell gene expression > Abstract
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“representing 61% of all expressed protein-coding genes and 49% of all lncRNAs, respectively”
§ Impact of genetic polymorphisms on human immune cell gene expression > RESULTS > Expression QTLs are highly cell-specific
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Strikingly, a large fraction (41%) of these genes showed a strong cis-association with genotype only in a single cell type.”
- Also stated in: § Abstract · plain
“a large fraction (41%) of these genes showed a strong cis-association with genotype only in a single cell type”
§ Impact of genetic polymorphisms on human immune cell gene expression > Abstract
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“which represent 61% of all protein-coding genes expressed in these cell types”
§ Impact of genetic polymorphisms on human immune cell gene expression > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interestingly, several lncRNAs showed high abundance in specific immune cell types.”
§ Impact of genetic polymorphisms on human immune cell gene expression > RESULTS > Cell-specific transcriptional signatures
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We also identified 2 genes in the Fc receptor like (FCRL) gene locus that showed strong cis-eQTLs primarily in TREG subsets”
§ Impact of genetic polymorphisms on human immune cell gene expression > RESULTS > CD4+ T cell subset-specific eQTLs
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“NCF4, which encodes neutrophilic cytosolic factor 4, a component of the NADPH oxidase complex, showed prominent cis-QTLs specifically in CD4+ T subsets”
§ Impact of genetic polymorphisms on human immune cell gene expression > RESULTS > CD4+ T cell subset-specific eQTLs
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Probably not a substantial claim. 17
- It may state two separate claims as one. 18
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“About 18% of these transcripts were long-noncoding RNAs (lncRNAs)”
§ Impact of genetic polymorphisms on human immune cell gene expression > RESULTS > Transcriptome of common human immune cell types
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Though a majority of transcripts were detected in multiple cell types (Fig. S1H,I), their relative abundance varied substantially, resulting in distinct clustering patterns of different cell types”
§ Impact of genetic polymorphisms on human immune cell gene expression > RESULTS > Transcriptome of common human immune cell types
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The PBC-risk variant rs74804869 influenced SYNGR1 expression in NK and also CD8+ T cells”
§ Impact of genetic polymorphisms on human immune cell gene expression > RESULTS > Cell types most susceptible to GWAS SNPs
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our eQTL analysis of CD4+ memory and TREG subsets yielded over 7,800 eGenes, of which >2,500 were unique to these subsets”
§ Impact of genetic polymorphisms on human immune cell gene expression > RESULTS > CD4+ T cell subset-specific eQTLs
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the CD-risk variant (rs9567293C/C) was associated with reduced expression of LACC1 in CD4+ memory T cell subsets, as well as in resting and activated naïve T cells but not in monocytes”
§ Impact of genetic polymorphisms on human immune cell gene expression > RESULTS > Cell types most susceptible to GWAS SNPs
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we found that the expression of NAB1 displayed prominent genotype-dependent association (rs13028201, adj. P = 1.41 × 10−14) only in NK cells”
§ Impact of genetic polymorphisms on human immune cell gene expression > RESULTS > Cell types most susceptible to GWAS SNPs
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“CCNG2, encoding for a cell cycle protein, cyclin G2, showed a peak eQTL (rs4859751) specifically in TH1/17 and TH17 cells although it was also highly expressed in other TH subsets and immune cell types”
§ Impact of genetic polymorphisms on human immune cell gene expression > RESULTS > CD4+ T cell subset-specific eQTLs
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“an RA-risk variant (rs3093026) and celiac disease-risk variant (rs7374671) that were associated with expression of chemokine receptor genes CCR6 and CCR2, respectively, in TH1/17 and TH17 subsets”
§ Impact of genetic polymorphisms on human immune cell gene expression > RESULTS > Cell types most susceptible to GWAS SNPs
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“1,875 unique transcripts, including 1,553 protein-coding transcripts and 196 lncRNAs, were differentially expressed between sexes”
§ Impact of genetic polymorphisms on human immune cell gene expression > RESULTS > Sex has major effects on immune cell gene expression
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We also found a cis-eQTL (rs1246642) whose impact on expression was stronger in female subjects (Fig. 6F,G and Fig. S6B,C); homozygous females carrying the CC versus TT genotype had 3.5-fold greater levels of FAM13A transcripts compared to a <1.5-fold increase in males.”
§ Impact of genetic polymorphisms on human immune cell gene expression > RESULTS > Sex has major effects on immune cell gene expression
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“TREG cells were most susceptible to the effects of several autoimmune disease-risk variants. Notable eGenes associated with these variants include IKZF4, PDE4A and PTGIR”
§ Impact of genetic polymorphisms on human immune cell gene expression > RESULTS > Cell types most susceptible to GWAS SNPs
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these results suggested that PBC-risk variants that modulate NAB1 and SYNGR1 expression are likely to impact NK cell function and influence PBC disease susceptibility.”
§ Impact of genetic polymorphisms on human immune cell gene expression > RESULTS > Cell types most susceptible to GWAS SNPs
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Overlap between GWAS SNPs and eQTLs indicates that the disease risk variant modulates expression of the linked gene in the susceptible cell type.
- Rests on an assumption: Knockdown of a gene in immune cells reflects the functional consequence of genetically reduced expression of that gene.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The identity of all individual RNA-Seq samples was confirmed by cross-comparison with genotyping data for a given subject by genome-wide analysis of SNPs overlapping exons.”
§ Impact of genetic polymorphisms on human immune cell gene expression > METHOD DETAILS > RNA-Seq analysis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Further, samples from each specific cell types were processed for RNASeq in one batch to avoid any experimental batch effects.”
§ Impact of genetic polymorphisms on human immune cell gene expression > METHOD DETAILS > RNA-Seq analysis
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Sex-biased transcripts were identified by performing pairwise comparison (female (n = 37) versus male (n = 54) subjects) using DESeq2 and considering ancestry and age as covariates; we considered a transcript expressed differentially when the DESeq2 analysis resulted in a Benjamini-Hochberg adj. P value of < 0.05.”
§ Impact of genetic polymorphisms on human immune cell gene expression > METHOD DETAILS > RNA-Seq analysis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The first two principal components of the genotyping data were used as covariates to minimize possible differences introduced by the different ancestry in the samples.”
§ Impact of genetic polymorphisms on human immune cell gene expression > METHOD DETAILS > Genotyping, imputation and determination of Eqtl
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The Institutional Review Board (IRB) of the La Jolla Institute for Allergy and Immunology (LJI; IRB protocol no. SGE-121–0714) approved the study.”
§ Impact of genetic polymorphisms on human immune cell gene expression > STAR METHODS > EXPERIMENTAL MODEL AND SUBJECT DETAILS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“To diminish the effects of possible outliers, the regularized log transformation of the DESeq2 package (Love et al., 2014) was applied and the homoscedastic data were then quantile-normalized.”
- Also stated in: § Genotyping, imputation and determination of Eqtl · plain
“The regularized log transformation of the DESeq2 package (Love et al., 2014) was applied and the homoscedastic data were then quantile-normalized to diminish the effects of possible outliers.”
§ Impact of genetic polymorphisms on human immune cell gene expression > METHOD DETAILS > RNA-Seq analysis
What the sources say
- Not checked yetcites Love et al., 2014 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Also stated in: § Genotyping, imputation and determination of Eqtl · plain
In the paper
“The data quality was assessed using the snpQC package (Gondro et al., 2014) for R v3.2.3 (http://www.R-project.org) and low-quality SNPs were removed for downstream analysis: SNPs failing in more than 5% of the samples and SNPs with Illumina’s GC scores less than 0.2 in more than 10% of the samples were filtered out.”
§ Impact of genetic polymorphisms on human immune cell gene expression > METHOD DETAILS > Genotyping, imputation and determination of Eqtl
What the sources say
- Not checked yetcites Gondro et al., 2014 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
In the paper
“To define the collection of SNPs from GWAS studies, we downloaded the dataset of the Phenotype-Genotype Integrator (PheGenI) (Ramos et al., 2014), which merges NHGRI GWAS Catalog data with several databases of the National Center for Biotechnology Information (NCBI), including Gene, dbGaP, OMIM, eQTL and dbSNP (September 2017; https://www.ncbi.nlm.nih.gov/gap/phegeni).”
- Also stated in: § GWAS SNP database construction and analysis · plain
“the resulting catalog of SNP-trait associations included 14,321 significant associations (lead GWAS SNPs; defined as P < 5 × 10−8) and 846 distinct phenotypes/traits.”
§ Impact of genetic polymorphisms on human immune cell gene expression > METHOD DETAILS > GWAS SNP database construction and analysis
What the sources say
- Not checked yetcites Ramos et al., 2014 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Also stated in: § GWAS SNP database construction and analysis · plain
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Transcripts with mean TPM < 1.0 across all samples of a given cell type were excluded from the analysis.”
§ Impact of genetic polymorphisms on human immune cell gene expression > METHOD DETAILS > RNA-Seq analysis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, the products of autoimmune risk-eGenes PDE4A and PTGIR are likely to modulate cAMP-mediated immunoregulation and influence disease pathogenesis.”
§ Impact of genetic polymorphisms on human immune cell gene expression > RESULTS > Cell types most susceptible to GWAS SNPs
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Notably, the eQTL analysis did not cover the pseudoautosomal regions of chr X or chr Y, thereby slightly lowering the annotated transcript count from 57,820 to 57,215 (605 missing genes).”
§ Impact of genetic polymorphisms on human immune cell gene expression > METHOD DETAILS > Genotyping, imputation and determination of Eqtl
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“SNPs missing for more than 5% of the samples or with a minimum allele frequency (MAF) lower than 5% were removed from the analysis.”
§ Impact of genetic polymorphisms on human immune cell gene expression > METHOD DETAILS > Genotyping, imputation and determination of Eqtl
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Briefly, transcripts with low expression values – the bottom one-third of all transcripts for at least 80% of the samples – were filtered out.”
§ Impact of genetic polymorphisms on human immune cell gene expression > METHOD DETAILS > Genotyping, imputation and determination of Eqtl
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The cohort consisted of 54 males and 37 female subjects with a median age of 27 years (range 18 to 61 years).”
§ Impact of genetic polymorphisms on human immune cell gene expression > STAR METHODS > EXPERIMENTAL MODEL AND SUBJECT DETAILS
plainn = 91- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Samples failing any quality control step (RNA quality and quantity, PCR amplification, library fragment size) were eliminated from further downstream steps.”
- Also stated in: § QUANTIFICATION AND STATISTICAL ANALYSIS · plain
“Any samples failing established quality controls (QC) were eliminated from downstream analysis; assay details and QCs on RNA-Seq samples included are provided in Table S1B (1,544 samples in total).”
§ Impact of genetic polymorphisms on human immune cell gene expression > METHOD DETAILS > RNA sequencing
plainn = 1,544- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Also stated in: § QUANTIFICATION AND STATISTICAL ANALYSIS · plain
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Sequencing library preparation steps were performed in a 96-well format, utilizing the automated platform Biomek FXP (Beckman Coulter), to reduce assay-to-assay variability.”
§ Impact of genetic polymorphisms on human immune cell gene expression > METHOD DETAILS > RNA sequencing
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“A total of 91 healthy volunteers were recruited in the San Diego area, who provided leukapheresis samples at the San Diego Blood Bank (SDBB) after written informed consent.”
§ Impact of genetic polymorphisms on human immune cell gene expression > STAR METHODS > EXPERIMENTAL MODEL AND SUBJECT DETAILS
plainn = 91- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“All study subjects self-reported ethnicity and race details, and were tested negative for hepatitis B, hepatitis C and human immunodeficiency virus (HIV).”
§ Impact of genetic polymorphisms on human immune cell gene expression > STAR METHODS > EXPERIMENTAL MODEL AND SUBJECT DETAILS
plainn = 91- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper relies on this without support.
Overlap between GWAS SNPs and eQTLs indicates that the disease risk variant modulates expression of the linked gene in the susceptible cell type.
“To shed light on the disease relevance of the eQTLs identified in human immune cells, we next focused on the subset of eGenes linked to eQTLs that directly overlapped haploblocks of significant GWAS SNPs”
The paper relies on this without support.
Knockdown of a gene in immune cells reflects the functional consequence of genetically reduced expression of that gene.
“As a first step in that process, we knocked down these genes in human NK cells and tested their impact on NK cell activity”
The paper relies on this without support.
The 13 immune cell types and activation conditions studied are representative enough of human immune cells to generalize eQTL and sex-biased expression findings.
“The cell types presented here comprise over 60% of all circulating mononuclear cells”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Within these correlated gene sets were genes known to be enriched or functionally important in the memory T cell subset driven by the TF in question, such as IL4R for GATA3 and CTLA4 for both Helios and FOXP324.”
From NEAT-seq: simultaneous profiling of intra-nuclear proteins, chromatin accessibility and gene expression in single cells (2022) · cites this paper as [24]
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L. S., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,682
Sex differences in immune responses
Klein, S. L., & Flanagan, K. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.90 · Cited by 6,370
Integrative analysis of 111 reference human epigenomes
Roadmap Epigenomics Consortium, Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., Wang, J., et al. (2015) · Nature · doi:10.1038/nature14248 · Cited by 6,368 · cited 1×
“…large-scale epigenomic initiatives analyzing multiple human cell types have attributed cis-regulatory function to nearly 20% of the non-coding DNA sequences, and showed that disease risk variants are enriched in cell-specific cis-regulatory DNA sequences (Roadmap Epigenomics et al., 2015).”
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
The GTEx Consortium, Ardlie, K. G., Deluca, D. S., Segrè, A. V., Sullivan, T. J., Young, T. R., Gelfand, E. T., Trowbridge, C. A., Maller, J. B., Tukiainen, T., et al. (2015) · Science · doi:10.1126/science.1262110 · Cited by 5,062
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Héry-Arnaud, G., Berre, R. L., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 5,008
Cited by
Sorted by citations
Items 201–300 of 894
Cruz, J. C., Allison, K. C., Page, L. S., Jenkins, A. J., Wang, X., Earp, H. S., Frye, S. V., Graham, D. K., Verneris, M. R., & Lee‐Sherick, A. B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1146721 · Cited by 28
Interleukin 23 receptor: Expression and regulation in immune cells
Mezghiche, I., Yahia‐Cherbal, H., Rogge, L., & Bianchi, E. (2023) · European Journal of Immunology · doi:10.1002/eji.202250348 · Cited by 32
Kasela, S., Aguet, F., Kim-Hellmuth, S., Brown, B. C., Nachun, D. C., Tracy, R. P., Durda, P., Liu, Y., Taylor, K. D., Johnson, W. C., et al. (2024) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2023.11.013 · Cited by 29
Update on the genetics of allergic diseases
Lawson, L. P., Parameswaran, S., Panganiban, R. A. M., Constantine, G. M., Weirauch, M. T., & Kottyan, L. C. (2025) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2025.03.012 · Cited by 33
Chinese Immune Multi-Omics Atlas
Yin, J., Zheng, Y., Huang, Z., Zhou, W., Yuan, Y., Cai, P., Bai, Y., Yang, S., Gao, Y., Duan, S., et al. (2026) · Science · doi:10.1126/science.adt3130 · Cited by 36
The Cancer-Associated Genetic Variant Rs3903072 Modulates Immune Cells in the Tumor Microenvironment
Zhang, Y., Manjunath, M., Yan, J., Baur, B. A., Zhang, S., Roy, S., & Song, J. S. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00754 · Cited by 27
Menegatti, S., Guillemot, V., Latis, E., Yahia‐Cherbal, H., Mittermüller, D., Rouilly, V., Mascia, E., Rosine, N., Koturan, S., Millot, G. A., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-218304 · Cited by 27
Sima, L. E., Chen, S., Cárdenas, H., Zhao, G., Wang, Y., Ivan, C., Huang, H., Zhang, B., & Matei, D. E. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002682 · Cited by 27
Pei, G., Yan, F., Simon, L. M., Dai, Y., Jia, P., & Zhao, Z. (2022) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2022.04.001 · Cited by 27
Nguyen, D. T., Kleczko, E. K., Dwivedi, N., Monaghan, M. T., Gitomer, B. Y., Chonchol, M. B., Clambey, E. T., Nemenoff, R. A., Klawitter, J., & Hopp, K. (2022) · JCI Insight · doi:10.1172/jci.insight.154773 · Cited by 28
Zhang, B., Zhang, Z., Koeken, V. A. C. M., Kumar, S., Aillaud, M., Tsay, H.-C., Liu, Z., Kraft, A. R. M., Soon, C. F., Odak, I., et al. (2022) · Cell Genomics · doi:10.1016/j.xgen.2022.100232 · Cited by 26
Larangé, A., Takazawa, I., Kakugawa, K., Thiault, N., Ngoi, S., Olive, M. E., Iwaya, H., Seguin, L., Vicente-Suarez, I., Bécart, S., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.07.017 · Cited by 27
Self-citationxQTLbiolinks: a comprehensive and scalable tool for integrative analysis of molecular QTLs
Ding, R., Zou, X., Qin, Y., Gong, L., Chen, H., Ma, X., Guang, S., Chen, Y., Wang, G., & Li, L. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad440 · Cited by 25
Asimit, J. L., Rainbow, D. B., Fortune, M. D., Grinberg, N. F., Wicker, L. S., & Wallace, C. (2019) · Nature Communications · doi:10.1038/s41467-019-11271-0 · Cited by 25
Quistrebert, J., Orlova, M., Kerner, G., Ton, L. T., Luong, N. T., Danh, N. T., Vincent, Q. B., Jabot‐Hanin, F., Seeleuthner, Y., Bustamante, J. C., et al. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009392 · Cited by 26
Tang, Y., Xu, Q., Hu, L., Yan, X., Feng, X., Yokota, A., Wang, W., Zhan, D., Krishnamurthy, D., Ochayon, D. E., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0833 · Cited by 26
Wang, Z., Liang, Q., Qian, X., Hu, B., Zheng, Z., Wang, J., Hu, Y., Bao, Z., Zhao, K., Zhou, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36897-z · Cited by 29
Effector memory–type regulatory T cells display phenotypic and functional instability
Wendering, D. J., Amini, L., Schlickeiser, S., Farrera-Sal, M., Schulenberg, S., Peter, L., Mai, M., Vollmer, T., Du, W., Stein, M., et al. (2024) · Science Advances · doi:10.1126/sciadv.adn3470 · Cited by 25
The impact of sex on HIV immunopathogenesis and therapeutic interventions
Mihealsick, E., Word, A., & Scully, E. P. (2024) · Journal of Clinical Investigation · doi:10.1172/jci180075 · Cited by 27
Burel, J. G., Singhania, A., Dubelko, P., Müller, J., Tanner, R., Parizotto, E. A., Dedicoat, M. J., Fletcher, T. E., Dunbar, J., Cunningham, A. F., et al. (2021) · Tuberculosis · doi:10.1016/j.tube.2021.102127 · Cited by 24
Self-citationTanwar, V. S., Reddy, M. A., Das, S., Samara, V. A., Abdollahi, M., Dey, S., Malek, V., Ganguly, R., Stapleton, K., Lanting, L. L., et al. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.318536 · Cited by 25
Mitsui, Y., Suzuki, T., Kuniyoshi, K., Inamo, J., Yamaguchi, K., Komuro, M., Watanabe, J., Edamoto, M., Li, S., Kouno, T., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.06.013 · Cited by 27
Aydin, E., Faehling, S., Saleh, M., Cid, L. L., Seiffert, M., & Roessner, P. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.595818 · Cited by 25
The genetics of autoimmune Addison disease: past, present and future
Røyrvik, E. C., & Husebye, E. S. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00653-y · Cited by 26
Functional Characterization of Genetic Variant Effects on Expression
Flynn, E. D., & Lappalainen, T. (2022) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-122120-010010 · Cited by 24
Chihab, L. Y., Kuan, R., Phillips, E. J., Mallal, S. A., Rozot, V., Davis, M. M., Scriba, T. J., Sette, A., Peters, B., Arlehamn, C. S. L., et al. (2022) · HLA · doi:10.1111/tan.14880 · Cited by 25
Self-citationMacrophages Do Not Express the Phagocytic Receptor BAI1/ADGRB1
Hsiao, C., van der Poel, M., van Ham, T. J., & Hamann, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00962 · Cited by 24
Ha, E., Bang, S., Lim, J., Yun, J. H., Kim, J., Bae, J.-B., Lee, H., Kim, B.-J., Kim, K.-W., & Bae, S. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-219152 · Cited by 24
An autoimmune transcriptional circuit drives FOXP3 + regulatory T cell dysfunction
Sumida, T. S., Lincoln, M. R., He, L., Park, Y., Ota, M., Oguchi, A., Son, R., Yi, A., Stillwell, H. A., Leissa, G. A., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adp1720 · Cited by 25
Ramírez‐Bello, J., Fragoso, J. M., Alemán‐Ávila, I., Jiménez‐Morales, S., Campos-Parra, A. D., Barbosa‐Cobos, R. E., & Moreno, J. G. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00058 · Cited by 23
Kushnareva, Y., Mathews, I. T., Andreyev, A. Y., Altay, G., Arlehamn, C. S. L., Vijayanand, P., Nilsson, R., Jain, M., Sette, A., Peters, B., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000672 · Cited by 23
Self-citationNassir, N., Tambi, R., Bankapur, A., Heialy, S. A., Karuvantevida, N. S., Khansaheb, H. H., Zehra, B., Begum, G., Hameid, R. A., Ahmed, A., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103030 · Cited by 24
Proximal and distal effects of genetic susceptibility to multiple sclerosis on the T cell epigenome
Roostaei, T., Klein, H., Ma, Y., Felsky, D., Kivisäkk, P., Connor, S. M., Kroshilina, A., Yung, C. J., Kaskow, B. J., Shao, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27427-w · Cited by 24
Dissection of multiple sclerosis genetics identifies B and CD4+ T cells as driver cell subsets
Guo, M. H., Sama, P., LaBarre, B. A., Lokhande, H. A., Balibalos, J., Chu, C., Du, X., Kheradpour, P., Kim, C. C., Oniskey, T. K., et al. (2022) · Genome biology · doi:10.1186/s13059-022-02694-y · Cited by 23
Novel eIF4A1 inhibitors with anti‐tumor activity in lymphoma
Kayastha, F. B., Herrington, N. B., Kapadia, B. B., Roychowdhury, A., Nanaji, N. M., Kellogg, G. E., & Gartenhaus, R. B. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00534-0 · Cited by 24
Nemeth, Z. H., Hildebrandt, E., Parsa, N., Fleming, A. B., Wasson, R., Pittman, K., Bell, X., Granger, J. P., Ryan, M. J., & Drummond, H. A. (2022) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00207.2022 · Cited by 24
OpenXGR: a web-server update for genomic summary data interpretation
Bao, C., Wang, S., Jiang, L., Fang, Z., Zou, K., Lin, J. C.-J., Chen, S., & Fang, H. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad357 · Cited by 22
Medina, T. D. S., Murison, A., Smith, M. I., Kinker, G. S., Chakravarthy, A., Vitiello, G. A. F., Turpin, W., Shen, S. Y., Yau, H. L., Sarmento, O. F., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1161901 · Cited by 25
Satô, K., Hara‐Chikuma, M., Yasui, M., Inoue, J., & Kim, Y. (2024) · iScience · doi:10.1016/j.isci.2024.109903 · Cited by 31
Mentzer, A. J., Dilthey, A., Pollard, M., Gurdasani, D., Karakoç, E., Carstensen, T., Muhwezi, A., Cutland, C., Diarra, A., Antunes, R. D. S., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02944-5 · Cited by 28
Self-citationBlanton, L. V., Roman, A. K. S., Wood, G., Buscetta, A. J., Banks, N., Skaletsky, H., Godfrey, A. K., Pham, T. T., Hughes, J. F., Brown, L. G., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100628 · Cited by 23
Sati, S., Huang, J., Kersh, A. E., Jones, P., Ahart, O., Murphy, C. M., Prouty, S. M., Hedberg, M. L., Jain, V., Gregory, S. G., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci178711 · Cited by 23
Peripheral blood mononuclear cells preferentially activate 11-oxygenated androgens
Schiffer, L., Bossey, A., Kempegowda, P., TAYLOR, A. E. R., Akerman, İ., Scheel‐Toellner, D., Storbeck, K., & Arlt, W. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1077 · Cited by 22
Henry, S., Trousdell, M. C., Cyrill, S. L., Zhao, Y., Feigman, M. J., Bouhuis, J. M., Aylard, D. A., Siepel, A. C., & dos Santos, C. O. (2021) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-021-09486-3 · Cited by 22
Lozano, M. L., Segú-Vergés, C., Coma, M., Román, M. T. Á., González‐Porras, J. R., Gutiérrez, L., Valcárcel, D., & Butta, N. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136907 · Cited by 22
Anvari, S., Watkin, L. B., Rajapakshe, K., Hassan, O., Schuster, K. F., Coarfa, C., & Davis, C. M. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108820 · Cited by 22
Byrnes, J. R., Weeks, A. M., Shifrut, E., Carnevale, J. C., Kirkemo, L. L., Ashworth, A., Marson, A., & Wells, J. A. (2022) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2022.100217 · Cited by 23
He, L., Loika, Y., & Kulminski, A. M. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01913-1 · Cited by 24
Pankratov, V., Yunusbaeva, M. M., Ryakhovsky, S. S., Zarodniuk, M., Metspalu, A., Nelis, M., Milani, L. A., Mägi, R., Esko, T., & Yunusbayev, B. (2022) · Nature Communications · doi:10.1038/s41467-022-34461-9 · Cited by 22
Cordeiro, B., Ahn, J. J., Gawde, S., Ucciferri, C. C., Álvarez‐Sánchez, N., Revelo, X. S., Stickle, N. H., Massey, K., Brooks, D. G., Guthridge, J. M., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.07.017 · Cited by 23
CD200R1-CD200 checkpoint inhibits phagocytosis differently from SIRPα-CD47 to suppress tumor growth
Li, J., Wang, Z., Qin, X., Zhong, M., Tang, Z.-H., Qian, J., Dou, J., Hussell, T., King, P. D., Nunès, J. A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60456-3 · Cited by 22
Multiple Targets for Oxysterols in Their Regulation of the Immune System
Reinmuth, L., Hsiao, C., Hamann, J., ROSENKILDE, M. M., & Mackrill, J. J. (2021) · Cells · doi:10.3390/cells10082078 · Cited by 22
Yoo, K. J., Johannes, K., Gonzalez, L. E., Patel, A., Shuptrine, C. W., Opheim, Z., Lenz, K. L., Campbell, K., Nguyen, T., Miriyala, J., et al. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2101175 · Cited by 22
PIM kinases regulate early human Th17 cell differentiation
Buchacher, T., Shetty, A., Koskela, S. A., Smolander, J., Kaukonen, R., Sousa, A. G. G., Junttila, S., Laiho, A., Rundquist, O., Lönnberg, T., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113469 · Cited by 22
A landscape of gene expression regulation for synovium in arthritis
Jiang, F., Hu, S., Tian, W., Wang, N., Yang, N., Dong, S., Song, H.-M., Zhang, D., Gao, H.-W., Wang, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45652-x · Cited by 24
Radionuclide partitioning coefficients in soils and plants and their correlation.
Sheppard, M. I. (1985) · PubMed · Cited by 21
Identifying genetic variants that influence the abundance of cell states in single-cell data
Rumker, L., Sakaue, S., Reshef, Y., Kang, J. B., Yazar, S., Alquicira-Hernández, J., Valencia, C., Lagattuta, K. A., Mah-Som, A. Y., Nathan, A., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01909-1 · Cited by 19
Immunological clues to sex differences in parasitic diseases
Sellau, J., Hansen, C. S., Gálvez, R. I., Linnemann, L. C., Honecker, B., & Lotter, H. (2024) · Trends in Parasitology · doi:10.1016/j.pt.2024.09.006 · Cited by 20
Tracing the Evolution of Human Immunity Through Ancient DNA
Patin, É., & Quintana‐Murci, L. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082323-024638 · Cited by 21
Xiao, Q., Yu, H., & Zhu, X. M. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104423 · Cited by 20
Hu, G., Gao, F., Wang, G., Fang, Y., Guo, Y., Zhou, J., Gu, Y., Zhang, C., Gao, N., Wen, Q., et al. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03038-3 · Cited by 20
Yang, Z., Deng, Y., Cheng, J., Wei, S., Luo, H., & Liu, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.695006 · Cited by 20
CD4+CCR6+ T cells dominate the BCG-induced transcriptional signature
Singhania, A., Dubelko, P., Kuan, R., Chronister, W. D., Muskat, K., Das, J., Phillips, E. J., Mallal, S. A., Seumois, G., Vijayanand, P., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103746 · Cited by 17
Self-citationClay, S. M., Schoettler, N., Goldstein, A. M., Carbonetto, P. S., Dapas, M., Altman, M. C., Rosasco, M. G., Gern, J. E., Jackson, D. J., Im, H. K., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01058-2 · Cited by 20
Fang, D., Li, Y., He, B. H., Gu, D., Zhang, M., Guo, J., Ren, H., Li, X., Zhang, Z., Tang, M., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.06.012 · Cited by 20
Baseline immune states (BIS) associated with vaccine responsiveness and factors that shape the BIS
Nehar-Belaid, D., Sokolowski, M. J., Ravichandran, S., Banchereau, J., Chaussabel, D., & Ucar, D. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101842 · Cited by 19
Wu, M., Valença-Pereira, F., Cendali, F. I., Giddings, E. L., Pham‐Danis, C., Yarnell, M. C., Novak, A. J., Brunetti, T. M., Thompson, S. B., Henao‐Mejia, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48653-y · Cited by 22
Popp, J. M., Rhodes, K., Jangi, R., Li, M., Barr, K., Tayeb, K., Battle, A. J., & Gilad, Y. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100701 · Cited by 22
Chen, X., Guo, M., Duan, Y.-Y., Jiang, F., Wu, H., Dong, S., Zhou, X., Thynn, H. N., Liu, C., Zhang, L., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.136477 · Cited by 19
Wu, Y., Jennings, N. B., Sun, Y., Dasari, S. K., Bayraktar, E., Corvigno, S., Stur, E., Glassman, D., Mangala, L. S., Ahumada, A. L., et al. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03885-z · Cited by 19
Álvarez‐Sánchez, N., & Dunn, S. E. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_324 · Cited by 21
Proteomics profiling of CD4 + T-cell-derived exosomes from patients with rheumatoid arthritis
Huang, L., Liang, L., Ji, Z., Chen, S., Liu, M., Huang, Z., Huang, Z., Sun, S., Ding, J., Chen, J., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110560 · Cited by 19
Leckie-Harre, A., Silverman, I., Wu, H., Humphreys, B. D., & Malone, A. F. (2023) · Transplantation · doi:10.1097/tp.0000000000004762 · Cited by 19
Langguth, M., Maranou, E., Koskela, S. A., Elenius, O., Kallionpää, R., Birkman, E., Pulkkinen, O. I., Sundvall, M., Salmi, M., & Figueiredo, C. R. (2024) · Genes and Immunity · doi:10.1038/s41435-024-00274-7 · Cited by 22
Matin, F., Jeet, V., Srinivasan, S., Cristino, A. S., Panchadsaram, J., Clements, J. A., & Batra, J. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2018.295824 · Cited by 19
Pomaznoy, M., Kuan, R., Lindvall, M., Burel, J. G., Seumois, G., Vijayanand, P., Taplitz, R., Gilman, R. H., Saito, M., Lewinsohn, D. M., et al. (2020) · ImmunoHorizons · doi:10.4049/immunohorizons.2000031 · Cited by 19
Self-citationCasasola-LaMacchia, A., Ritorto, M. S., Seward, R., Ahyi-Amendah, N., Ciarla, A., Hickling, T. P., & Neubert, H. (2021) · Scientific Reports · doi:10.1038/s41598-020-77024-y · Cited by 19
Arlehamn, C. S. L., Benson, B., Kuan, R., Dill‐McFarland, K. A., Peterson, G. J., Paul, S., Nguyen, F. K., Gilman, R. H., Saito, M., Taplitz, R., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1016038 · Cited by 18
Chen, H. V., Lorenzini, M. H., Lavalle, S. N., Sajeev, K., Fonseca, A., Fiaux, P. C., Sen, A., Luthra, I., Ho, A. J., Chen, A. R., et al. (2023) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2023.03.008 · Cited by 15
Self-citationSakkas, L. I., & Chikanza, I. C. (2023) · Rheumatology International · doi:10.1007/s00296-023-05446-8 · Cited by 20
IgG glycosylation associates with risk of progression from latent to active tuberculosis.
Burel, J. G., Wang, W., Wuhrer, M., Dedicoat, M., Fletcher, T., Cunningham, A., & O'Shea, M. K. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.01.014 · Cited by 17
Yuan, C., Liu, L., Zhao, Y., & Wang, K. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18550 · Cited by 18
Chen, J., Crouch, E. E., Zawadzki, M. E., Jacobs, K. A., Mayo, L. N., Choi, J. J.-Y., Lin, P.-Y., Shaikh, S., Tsui, J. L., González-Granero, S., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01769-2 · Cited by 18
Barrios, E. L., Leary, J. R., Darden, D. B., Rincon, J. C., Willis, M. L., Polcz, V. E., Gillies, G. S., Munley, J. A., Dirain, M. L. S., Ungaro, R. F., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1355405 · Cited by 18
Th1-poised naive CD4 T cell subpopulation reflects anti-tumor immunity and autoimmune disease
Yoon, J.-W., Kim, K. M., Cho, S., Cho, M.-J., Park, S., Hwang, D., Kim, H. R., Park, S. H., Cho, J.-H., Jeong, H., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57237-3 · Cited by 17
The Pseudokinase TRIB1 in Immune Cells and Associated Disorders
Danger, R., Feseha, Y., & Brouard, S. (2022) · Cancers · doi:10.3390/cancers14041011 · Cited by 17
Lessons From Transcriptome Analysis of Autoimmune Diseases
Nagafuchi, Y., Yanaoka, H., & Fujio, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.857269 · Cited by 19
González‐Serna, D., Shi, C., Kerick, M., Hankinson, J., Ding, J., McGovern, A., Tutino, M., Villanueva-Martín, G., Ortego‐Centeno, N., Callejas-Rubio, J. L., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42396 · Cited by 19
Integrated Molecular Analysis Reveals 2 Distinct Subtypes of Pure Seminoma of the Testis
Medvedev, K. E., Savelyeva, A., Chen, K. S.-M., Bagrodia, A., Jia, L., & Grishin, N. V. (2022) · Cancer Informatics · doi:10.1177/11769351221132634 · Cited by 17
Seminoma subtypes differ in the organization and functional state of the immune microenvironment
Savelyeva, A., & Medvedev, K. E. (2023) · 3 Biotech · doi:10.1007/s13205-023-03530-1 · Cited by 17
Endothelial cell plasticity in kidney fibrosis and disease
Pohl, L., & Schießl, I. M. (2023) · Acta Physiologica · doi:10.1111/apha.14038 · Cited by 20
Scarpa, J. R., Montagna, G., Plitas, G., Gulati, A., Fischer, G. W., & Mincer, J. S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1267532 · Cited by 17
Clinical and Real-World Effectiveness of Mogamulizumab: A Narrative Review
Fernández-Guarino, M., Ortiz-Romero, P. L., Gallardo, F., & Llamas‐Velasco, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042203 · Cited by 17
Shaping immunity: The influence of natural selection on population immune diversity
Randolph, H. E., Aracena, K. A., Lin, Y., Mu, Z., & Barreiro, L. B. (2024) · Immunological Reviews · doi:10.1111/imr.13329 · Cited by 20
He, J., Chen, Y., Ding, H., Zhou, J., Xing, Z., Yang, X., Fan, Q., Zuo, Y., Wang, T., & Cheng, J. (2024) · Journal of Clinical Investigation · doi:10.1172/jci176586 · Cited by 17
Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo
Cooney, J. P., Hirons, A., Jansz, N., Allison, C. C., Hickey, P. F., Teh, C. E., Tan, T., Dagley, L. F., Yousef, J. M., Yurick, D., et al. (2025) · Cell · doi:10.1016/j.cell.2025.06.023 · Cited by 16
McGinnis, C. S., Siegel, D. A., Xie, G., Hartoularos, G. C., Stone, M., Ye, C., Gartner, Z. J., Roan, N. R., & Lee, S. A. (2021) · BMC Biology · doi:10.1186/s12915-020-00941-x · Cited by 16
Ban, M., Bredikhin, D., Huang, Y., Bonder, M. J., Katarzyna, K., Oliver, A. J., Wilson, N. K., Coupland, P. G., Hadfield, J., Göttgens, B., et al. (2023) · Brain · doi:10.1093/brain/awad404 · Cited by 15
Olyha, S. J., O’Connor, S. K., Kribis, M., Bucklin, M. L., Kumar, D. B. U., Tyler, P. M., Alam, F., Jones, K. M., Sheikha, H., Konnikova, L., et al. (2024) · Journal of Clinical Immunology · doi:10.1007/s10875-023-01610-8 · Cited by 17
Alda-Catalinas, C., Ibarra-Soria, X., Flouri, C., Gordillo, J. E., Cousminer, D. L., Hutchinson, A., Sun, B., Pembroke, W. G., Ullrich, S., Krejčí, A., et al. (2024) · Genome biology · doi:10.1186/s13059-024-03176-z · Cited by 18
Metadata
- Authors
- Schmiedel, B. J., Singh, D., Madrigal, A., Valdovino-Gonzalez, A. G., White, B. M., Zapardiel-Gonzalo, J., Ha, B., Altay, G., Greenbaum, J. A., McVicker, G., Seumois, G., Rao, A., Kronenberg, M., Peters, B., & Vijayanand, P.
- Affiliations
- La Jolla Institute for Immunology (US)
- Salk Institute for Biological Studies (US)
- Corresponding author
- Vijayanand, Pandurangan
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2018-11
- Volume
- 175
- Issue
- 6
- Pages
- 1701-1715.e16
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC6289654
- OpenAlex
- W2901765988
- Semantic Scholar
- 0b385de9f5adec440b108379bcbf8f8f00d13552
- Cited by
- 867
- References
- 68
- Citations by year
- 2026: 87 · 2025: 124 · 2024: 148 · 2023: 114 · 2022: 137 · 2021: 133 · 2020: 77 · 2019: 43 · 2018: 2
- FWCI
- 39.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- B.P. Koirala Institute of Health Sciences (S10RR027366, S10OD016262)
- National Institutes of Health (R24 AI108564)
- William K. Bowes, Jr. Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
- Keywords
- genetic polymorphism, immune cell gene expression, cis-eQTL, expression quantitative trait loci, single-cell transcriptomics, sex differences in gene expression, cell type-specific gene regulation, immune cell types
- MeSH terms
- Adolescent, Adult, Female, Gene Expression Regulation, Genotype, Humans, Male, Middle Aged, Sex Characteristics, Polymorphism, Single Nucleotide, Gene Expression Profiling, Quantitative Trait Loci, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
